Earnings Call · Q2 FY2026·2026-08-05

Q2 26EPS +56.67%·Rev n/aQ1 26EPS +13.79%·Rev n/aQ4 25EPS +58.33%·Rev n/aQ3 25EPS n/a·Rev n/a⚠ consensus missing

Medline Inc. MDLN

Karen King — Investor Relations

Jim Boyle — Chief Executive Officer

Mike Drazin — Chief Financial Officer

−12.8%1d on move date3d−16.2%5d−16.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MDLN calls or request research access.

More MDLN calls Browse calls Request research access